Emily Leproust, Twist CEO
Boehringer Ingelheim taps a popular antibody discovery player for access to drug 'library of libraries'
Over the past two years, Twist Bioscience — one of the most relied upon companies in biotech and academia for its DNA synthesis services — has been …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
